Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | XIAP | P98170 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2569758 | 0.86 | RARB (0.50) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2572050 | 0.82 | FDPS (0.46) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2572917 | 0.82 | FDPS (0.46) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2572347 | 0.81 | CYP2D6 (0.42) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL20358289 | 0.80 | RARB (0.54) | RAB9ANPC1ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL27961862 | 0.79 | TDP1 (0.58) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL9227890 | 0.78 | KDM4E (0.47) | MAPTALDH1A1CYP3A4CYP2D6CYP1A2 | |
| SCHEMBL9227885 | 0.78 | KDM4E (0.47) | MAPTALDH1A1CYP3A4CYP2D6CYP1A2 | |
| SCHEMBL2396650 | 0.78 | NR5A1 (0.56) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL3791496 | 0.78 | NR5A1 (0.56) | MAPTRAB9ANPC1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078267-A1 | Organic semiconductors | ORC3, C1S, C5 | MAPT 1560/4885RAB9A 3778/4885NPC1 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.